Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer system in photodynamic cancer therapy

被引:95
作者
Sortino, S
Mazzaglia, A
Scolaro, LM
Merlo, FM
Valveri, V
Sciortino, MT
机构
[1] Univ Catania, Dipartimento Sci Chim, I-95125 Catania, Italy
[2] Univ Messina, CNR, ISMN, Unita Messina,Ist Studio Mat Nanostrutturati, I-98166 Messina, Italy
[3] Univ Messina, Dipartimento Chim Inorgan Chim Analit & Chim Fis, I-98166 Messina, Italy
[4] Univ Messina, Dipartimento Sci Microbiol Genet & Mol, I-98166 Messina, Italy
关键词
biocompatibility; cyclodextrins; drug delivery; photoexcitation; nanostructures; singlet oxygen;
D O I
10.1016/j.biomaterials.2006.03.035
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The photodynamic activity of a carrier-sensitizer system consisting of heterotopic colloidal nanoparticles (diameter 100-1000 nm) of a cationic amphiphilic cyclodextrin, heptakis(2-omega-amino-O-oligo(ethylene oxide) -6-hexylthio)-beta-CD (SC6CDNH2) encapsulating the anionic 5,10,15,20-tetrakis(4-sulfonatophenyl)-21H,23H-porphyrin (TPPS) is investigated by an interdisciplinary approach involving the combination of time-resolved absorption and emission techniques with in vitro studies on cultured tumor cells. In a range of TPPS:SC6CDNH2 molar ratios between 1:10 and 1:50 these nanoparticles preserve the photodynamic properties of the entrapped photoactive agent. In fact, the triplet state of TPPS is efficiently populated, very long-lived and, as a consequence, able to produce singlet oxygen (the essential species for the photodynamic action) with quantum yield comparable to the free TPPS. Photodynamic efficacy of the carrier/sensitizer system is proven by in vitro studies on tumor Hela cells treated with TPPS:SC6CDNH2 at different molar ratio, showing significant cells death upon illumination with visible light. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4256 / 4265
页数:10
相关论文
共 46 条
[1]   Metal complexes as photo- and radiosensitizers [J].
Ali, H ;
van Lier, JE .
CHEMICAL REVIEWS, 1999, 99 (09) :2379-2450
[2]   Current status of phthalocyanines in the photodynamic therapy of cancer [J].
Allen, CM ;
Sharman, WM ;
Van Lier, JE .
JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, 2001, 5 (02) :161-169
[3]  
[Anonymous], CANC MED
[4]  
Aveline BM, 1999, PHOTOCHEM PHOTOBIOL, V69, P306, DOI 10.1562/0031-8655(1999)069<0306:CCPBAP>2.3.CO
[5]  
2
[6]   Increase of the photosensitizing efficiency of the Bacteriochlorin a by liposome-incorporation [J].
Damoiseau, X ;
Schuitmaker, HJ ;
Lagerberg, JWM ;
Hoebeke, M .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2001, 60 (01) :50-60
[7]   Comparison of the photophysics of an aggregating and non-aggregating aluminium phthalocyanine system incorporated into unilamellar vesicles [J].
Dhami, S ;
Phillips, D .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 1996, 100 (1-3) :77-84
[8]   Cationic β-cyclodextrin bilayer vesicles [J].
Donohue, R ;
Mazzaglia, A ;
Ravoo, BJ ;
Darcy, R .
CHEMICAL COMMUNICATIONS, 2002, (23) :2864-2865
[9]   PHOTOSENSITIZERS - THERAPY AND DETECTION OF MALIGNANT-TUMORS [J].
DOUGHERTY, TJ .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1987, 45 (06) :879-889
[10]  
Henderson B.W., 1992, PHOTODYNAMICS THERAP